• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Ryan Specialty (RYAN) Stock Faces Margin Pressure Behind A 57.7x P/E

    Simply Wall St·08/01/2026 02:26:28
    Listen to the news

    Ryan Specialty Holdings slipped into this earnings print with the stock sitting almost flat on the day at US$44.16, even after a strong 90 day run. The market reaction so far looks muted for a quarter where organic revenue reached roughly US$917m and adjusted earnings per share came in at US$0.74.

    The real tension is between that earnings strength and a rich 57.7x P/E that already prices in a lot of optimism. For now, investors appear cautious rather than euphoric, treating the solid Q2 delivery as confirmation rather than a fresh catalyst.

    Is Ryan Specialty Holdings trading at an unjustified 57.7x P/E, or does the current US$44.16 price sit far below its earnings power and DCF work? Compare the stock's embedded expectations against our valuation analysis for Ryan Specialty Holdings

    Q2 2026 Earnings Summary

    • Revenue (Q2 2026 vs. Q2 2025): US$916.6m vs. US$840.9m (up about 9.0%)
    • Net Income, Excluding Extra Items (Q2 2026 vs. Q2 2025): US$42.3m vs. US$52.0m (down about 18.6%)
    • Basic EPS, Earnings Per Share (Q2 2026 vs. Q2 2025): US$0.34 vs. US$0.41 (down about 17.3%)
    • Trailing 12 Month Net Profit Margin (Q2 2026 vs. Q2 2025): 3.1% vs. 2.1% (improved by about 1.0 percentage point)

    Prefer clean charts instead of scrolling through more earnings tables and raw figures? See Ryan Specialty Holdings' overall valuation picture in a simple visual layout in our company report for Ryan Specialty Holdings.

    NYSE:RYAN Trailing 12-Month Earnings & Revenue History as at Aug 2026
    NYSE:RYAN Trailing 12-Month Earnings & Revenue History as at Aug 2026

    Evaluating Ryan Specialty’s Growth and Margin Ambitions

    Bulls argue Ryan Specialty can compound earnings through above market organic growth, better margins and smart capital allocation. Q2 gives some support to that script. Organic revenue rose 6.7% and 1H26 ran at 8.9%, which aligns with the idea of taking share in specialty and excess and surplus lines while property pricing softens. Wholesale brokerage held its property book better than expected and leaned on casualty, professional lines and construction wins, which fits the claim of benefiting from complex risk moving into specialty channels.

    The margin leg of the thesis is more mixed. Adjusted EBITDAC was up 6% and the margin of 35.7% dipped 40 bps as talent and infrastructure spend weighed, while guidance still calls for a 50 to 100 bps full year margin decline. That means the near term evidence is stronger on growth milestones than on the hoped for margin expansion story.

    Access the full timeline of where the surface looks calm but the models start to diverge so you can see where the consensus breaks on revenue, margins and EPS inflection points in the analyst estimates for Ryan Specialty Holdings.

    Ryan Specialty Bears See Margin Fears Validated

    The core worry around Ryan Specialty is that softer commercial P&C pricing, higher regulatory and compliance costs, and execution risk on growth projects will squeeze margins and make recent growth hard to repeat. This quarter does not dismiss that concern. Organic revenue grew 6.7% in Q2 and 8.9% in the first half, yet adjusted EBITDAC margin slipped to 35.7%, and management still expects a 50 to 100 bps margin decline for 2026. That is a clear miss versus the hope that scale and technology would already translate into margin expansion.

    Bears also question whether heavy investment and new initiatives can offset rising competition and legal overhangs. The ongoing securities investigations after weak 2025 results remain unresolved, and management flagged intensifying competition in casualty and binding authority. Together, that points to some of the structural risks in the bearish narrative showing up in the numbers, not just in theory.

    After margin compression, unresolved investigations, questions around debt coverage, and one off items, review our independent risk analysis for Ryan Specialty Holdings which shows 2 important warning signs

    Stay Ahead With Simply Wall St

    If the mix of solid revenue, margin questions and a 57.7x P/E has you watching Ryan Specialty Holdings closely, register for free with Simply Wall St and add it to a Watchlist to track share price against fair value and spot a potential entry point that suits your plan. Once you are invested, keep your holdings organised with the Portfolio Command Center that cuts through noise and focuses on the key developments that matter to your thesis. For a broader view, use the Community to tap into different investor perspectives and see how others are interpreting updates to Ryan Specialty Holdings. By surfacing hidden catalysts and risks early, Simply Wall St helps you move faster on informed decisions and stay ahead of the market.

    Seeking Alternatives Beyond Ryan Specialty Holdings?

    Fresh ideas move fast. Some stocks are building quiet momentum while others risk getting caught after they start flying. Check these under the radar lists before the crowd and act now.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.